Peter Terness
Heidelberg University
101 Papers
1K Citations
Peter Terness is an academic researcher from Heidelberg University. The author has contributed to research in topics: Transplantation & Antibody. The author has an hindex of 26, co-authored 93 publications.
Chat about Author
Papers
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
TL;DR: A review of the current literature indicates that the authors are far from understanding the biological relevance of IDO expression during tumorigenesis, and a better understanding ofIDO biology is needed to comprehend the effect of IDo inhibitors and to provide a rationale for their therapeutic application in cancer.
448
Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients.
TL;DR: Graft survival was significantly improved with Thymoglobulin and IL-2RA induction, whereas lymphoma rates were highest with ATGAM, OKT3, and Thymglobulin, the best risk-to-benefit ratio for this patient population overall in terms of graft survival and lymphoma.
173
Tolerance Signaling Molecules and Pregnancy: IDO, Galectins, and the Renaissance of Regulatory T Cells
Peter Terness,Marinos Kallikourdis,Alexander G. Betz,Gabriel A. Rabinovich,Shigeru Saito,David A. Clark +5 more
TL;DR: The concept of maternal tolerance preventing rejection of the semi‐allogeneic ‘fetal allograft’ is still valid and should be considered for use in clinical practice.
118
Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immunoglobulin variable region genes.
Martin Welschof,Peter Terness,F. Kolbinger,M. Zewe,Stefan Dübel,Heinz Dörsam,C. Hain,M. Finger,M Jung,Gerhard Moldenhauer,N. Hayashi,Melvyn Little,Gerhard Opelz +12 more
TL;DR: In this paper, a set of 15 primers for PCR amplification of variable immunoglobulin (Ig) genes were presented. But the primers were based on gene sequences and were not able to amplify a wide range of rearranged antibody variable region genes.
114
Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)–producing dendritic cells: too much ado about IDO?
TL;DR: Findings show that nonadherent CD123+/CCR6+ human DCs do not constitutively express IDO, and, even if they express the enzyme after IFN-gamma treatment, they possess only limited T-cell regulatory function.
105